Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-4 Registration of securities (foreign)
- 3.1 Exhibit 3.1
- 3.5 Exhibit 3.5
- 4.1 Exhibit 4.1
- 5.1 Exhibit 5.1
- 5.2 Exhibit 5.2
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.4 Exhibit 23.4
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- 99.6 Exhibit 99.6
- 99.7 Exhibit 99.7
- 99.8 Exhibit 99.8
- 99.9 Exhibit 99.9
- 99.10 Exhibit 99.10
- EX-FILING FEES Ex-filing Fees
Associated filings
- 21 Mar 23 6-K Casi Pharmaceuticals Completes Redomiciliation Merger
- 14 Feb 23 424B3 Prospectus supplement
- 13 Feb 23 EFFECT Notice of effectiveness
- 9 Feb 23 F-4/A Registration of securities (foreign) (amended)
-
31 Jan 23 F-4 Registration of securities (foreign)
CASI Pharmaceuticals similar filings
Filing view
External links